Adult Refsum Disease (PHYH)
Genetics
Autosomal recessive disease most often caused by biallelic pathogenic variants in PHYH and less commonly by PEX7 variants. The centre pipeline entry is specifically PHYH-related disease.
Molecular Mechanism
PHYH catalyzes the first step of peroxisomal alpha-oxidation of phytanic acid, which cannot undergo conventional beta-oxidation because of its 3-methyl group. Deficiency causes phytanic-acid accumulation in neural, retinal, cardiac and other lipid-rich tissues.
Therapy
Dietary restriction of phytanic acid and avoidance of fasting or rapid weight loss are effective and must begin early. Plasmapheresis or lipid apheresis is reserved for acute severe elevations, especially with arrhythmia. Established retinal and auditory damage may be irreversible.
CCP Activity
CCP is developing a PHYH-deficient model and a gene-replacement concept.
Mouse Models Mouse Models & Gene Cards
| Mouse Models | Gene Cards |
|---|---|
| TBD | TBD |